| scholarly article | Q13442814 |
| P50 | author | Hideaki Mabashi-asazuma | Q42767514 |
| Donald L Jarvis | Q59033612 | ||
| Kay-Hooi Khoo | Q62806297 | ||
| P2093 | author name string | Chu-Wei Kuo | |
| P2860 | cites work | Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol | Q27646366 |
| Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent | Q27679191 | ||
| Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6 | Q28115808 | ||
| The role of protein glycosylation in allergy | Q28267829 | ||
| Glycoproteins from insect cells: sialylated or not? | Q28362910 | ||
| Synthesis of the A-band polysaccharide sugar D-rhamnose requires Rmd and WbpW: identification of multiple AlgA homologues, WbpW and ORF488, in Pseudomonas aeruginosa | Q28493157 | ||
| Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines | Q30387030 | ||
| Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity | Q30835165 | ||
| Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells | Q30839474 | ||
| Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. | Q30873680 | ||
| Complex-type biantennary N-glycans of recombinant human transferrin from Trichoplusia ni insect cells expressing mammalian [beta]-1,4-galactosyltransferase and [beta]-1,2-N-acetylglucosaminyltransferase II. | Q30896380 | ||
| N-glycan patterns of human transferrin produced in Trichoplusia ni insect cells: effects of mammalian galactosyltransferase. | Q31799491 | ||
| Identification of core alpha 1,3-fucosylated glycans and cloning of the requisite fucosyltransferase cDNA from Drosophila melanogaster. Potential basis of the neural anti-horseadish peroxidase epitope. | Q31920930 | ||
| Fucosyltransferase substrate specificity and the order of fucosylation in invertebrates | Q33209986 | ||
| Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. | Q33232455 | ||
| Construction and characterization of new piggyBac vectors for constitutive or inducible expression of heterologous gene pairs and the identification of a previously unrecognized activator sequence in piggyBac. | Q33269616 | ||
| Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC | Q33307815 | ||
| Insect cells for antibody production: evaluation of an efficient alternative. | Q33866581 | ||
| Re-visiting the endogenous capacity for recombinant glycoprotein sialylation by baculovirus-infected Tn-4h and DpN1 cells | Q34169543 | ||
| SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells. | Q34224840 | ||
| Baculovirus expression of alkaline phosphatase as a reporter gene for evaluation of production, glycosylation and secretion | Q34247357 | ||
| Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system | Q34247472 | ||
| Multifarious roles of sialic acids in immunity | Q34270155 | ||
| Characterization of v-cath, a cathepsin L-like proteinase expressed by the baculovirus Autographa californica multiple nuclear polyhedrosis virus | Q34309370 | ||
| Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity | Q34346238 | ||
| Liquefaction of Autographa californica nucleopolyhedrovirus-infected insects is dependent on the integrity of virus-encoded chitinase and cathepsin genes | Q34449509 | ||
| Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies | Q34574834 | ||
| N- and O-linked oligosaccharides of allergenic glycoproteins | Q34582786 | ||
| Fast cloning inverted repeats for RNA interference | Q35110871 | ||
| Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system | Q35380617 | ||
| A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway. | Q35703121 | ||
| Alix protein is substrate of Ozz-E3 ligase and modulates actin remodeling in skeletal muscle | Q35874467 | ||
| Lepidopteran cells, an alternative for the production of recombinant antibodies? | Q35969904 | ||
| Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells | Q36392872 | ||
| Impact of a human CMP-sialic acid transporter on recombinant glycoprotein sialylation in glycoengineered insect cells | Q36491777 | ||
| Isolation and analysis of a baculovirus vector that supports recombinant glycoprotein sialylation by SfSWT-1 cells cultured in serum-free medium | Q36730542 | ||
| Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases. | Q36815622 | ||
| Functional mapping of a trans-activating gene required for expression of a baculovirus delayed-early gene | Q36857712 | ||
| Baculovirus late and very late gene regulation | Q36990061 | ||
| Glycosylation as a strategy to improve antibody-based therapeutics | Q37402407 | ||
| Anti-CD20 monoclonal antibodies: historical and future perspectives | Q37601775 | ||
| Baculovirus-insect cell expression systems. | Q37628072 | ||
| Production of therapeutic antibodies with controlled fucosylation | Q37672128 | ||
| Silkworm as a host of baculovirus expression | Q37704490 | ||
| Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2 | Q37705711 | ||
| Therapeutic antibodies: market considerations, disease targets and bioprocessing | Q37974006 | ||
| Obinutuzumab for the treatment of lymphoproliferative disorders | Q37979277 | ||
| Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks | Q37980587 | ||
| Engineering novel Lec1 glycosylation mutants in CHO-DUKX cells: molecular insights and effector modulation of N-acetylglucosaminyltransferase I. | Q38328602 | ||
| A fused lobes gene encodes the processing beta-N-acetylglucosaminidase in Sf9 cells | Q39262654 | ||
| Allergens of honey bee venom | Q39374694 | ||
| A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins. | Q39462326 | ||
| Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells. | Q39603349 | ||
| Evaluation of different glycoforms of honeybee venom major allergen phospholipase A2 (Api m 1) produced in insect cells. | Q39617938 | ||
| Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. | Q39690283 | ||
| N-Glycosylation engineering of lepidopteran insect cells by the introduction of the beta1,4-N-acetylglucosaminyltransferase III gene | Q39691893 | ||
| Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of alpha-1,3-core fucosylation. | Q39777897 | ||
| Transforming lepidopteran insect cells for continuous recombinant protein expression. | Q40064314 | ||
| False positive reactivity of recombinant, diagnostic, glycoproteins produced in High Five insect cells: effect of glycosylation | Q40080449 | ||
| Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics | Q40121790 | ||
| RNA interference of sialidase improves glycoprotein sialic acid content consistency | Q40284012 | ||
| Galatosylation and sialylation of mammalian glycoproteins produced by baculovirus-madiated gene expression in insect cells | Q40379619 | ||
| Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins | Q40523412 | ||
| Improvement of glycosylation in insect cells with mammalian glycosyltransferases | Q40659743 | ||
| The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity | Q40690773 | ||
| Mammalian glycosyltransferase expression allows sialoglycoprotein production by baculovirus-infected insect cells | Q40794881 | ||
| Engineering lepidopteran insect cells for sialoglycoprotein production by genetic transformation with mammalian beta 1,4-galactosyltransferase and alpha 2,6-sialyltransferase genes | Q40826999 | ||
| Adaptation of BTI-TN5B1-4 (high five) insect cells for large-scale production in a stirred bioreactor | Q40928552 | ||
| Stable expression of mammalian beta 1,4-galactosyltransferase extends the N-glycosylation pathway in insect cells. | Q41041039 | ||
| Inducing single-cell suspension of BTI-TN5B1-4 insect cells: I. The use of sulfated polyanions to prevent cell aggregation and enhance recombinant protein production | Q41110820 | ||
| Production of a urokinase plasminogen activator-IgG fusion protein (uPA-IgG) in the baculovirus expression system | Q41114836 | ||
| Modifying the insect cell N-glycosylation pathway with immediate early baculovirus expression vectors. | Q41160004 | ||
| Elongation of the N-glycans of fowl plague virus hemagglutinin expressed in Spodoptera frugiperda (Sf9) cells by coexpression of human beta 1,2-N-acetylglucosaminyltransferase I. | Q41221793 | ||
| Influence of promoter and signal peptide on the expression and secretion of recombinant porcine LH extracellular domain in baculovirus/lepidopteran cells or the caterpillar system | Q41339871 | ||
| Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. | Q41721001 | ||
| Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches | Q41899137 | ||
| The production of an active protein kinase C-delta in insect cells is greatly enhanced by the use of the basic protein promoter | Q42068147 | ||
| A method for producing recombinant baculovirus expression vectors at high frequency. | Q42070060 | ||
| The antigenicity of the carbohydrate moiety of an insect glycoprotein, honey-bee (Apis mellifera) venom phospholipase A2. The role of alpha 1,3-fucosylation of the asparagine-bound N-acetylglucosamine | Q42086759 | ||
| Towards abolition of immunogenic structures in insect cells: characterization of a honey-bee (Apis mellifera) multi-gene family reveals both an allergy-related core alpha1,3-fucosyltransferase and the first insect Lewis-histo-blood-group-related ant | Q42199636 | ||
| Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase | Q42966864 | ||
| Reconstitution in vitro of the GDP-fucose biosynthetic pathways of Caenorhabditis elegans and Drosophila melanogaster. | Q43491371 | ||
| A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. | Q50925449 | ||
| Temporal nature of the promoter and not relative strength determines the expression of an extensively processed protein in a baculovirus system. | Q52545647 | ||
| Improved expression of secreted and membrane-targeted proteins in insect cells. | Q52704860 | ||
| Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase F cannot release glycans with fucose attached alpha 1----3 to the asparagine-linked N-acetylglucosamine residue | Q67940170 | ||
| Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells | Q71545092 | ||
| Mass spectrometry of carbohydrate-containing biopolymers | Q72319512 | ||
| The asparagine-linked carbohydrate of honeybee venom hyaluronidase | Q72345349 | ||
| P433 | issue | 3 | |
| P921 | main subject | insect | Q1390 |
| P304 | page(s) | 325-340 | |
| P577 | publication date | 2013-12-20 | |
| P1433 | published in | Glycobiology | Q5572596 |
| P1476 | title | A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells | |
| P478 | volume | 24 |
| Q33893766 | A new insect cell glycoengineering approach provides baculovirus-inducible glycogene expression and increases human-type glycosylation efficiency |
| Q38301805 | Algal lectin binding to core (α1-6) fucosylated N-glycans: structural basis for specificity and production of recombinant protein |
| Q50883192 | Characterization of Recombinant Thermococcus kodakaraensis (KOD) DNA Polymerases Produced Using Silkworm-Baculovirus Expression Vector System. |
| Q34785036 | Engineering β1,4-galactosyltransferase I to reduce secretion and enhance N-glycan elongation in insect cells |
| Q39006079 | Humanizing glycosylation pathways in eukaryotic expression systems |
| Q41825921 | Minimizing fucosylation in insect cell-derived glycoproteins reduces binding to IgE antibodies from the sera of patients with allergy |
| Q36235945 | Targeted glycoengineering extends the protein N-glycosylation pathway in the silkworm silk gland |
| Q92461831 | The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics |
| Q39090094 | The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae |
| Q36361549 | The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruits |
| Q38547311 | Using glyco-engineering to produce therapeutic proteins. |
Search more.